Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  BioArctic AB    BIOA B   SE0010323311

BIOARCTIC AB

(BIOA B)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

BioArctic AB : annual earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/11/2019 | 09:15am EST

The company will report its earnings for FY 2018 on 02/14/2019. Generally, the company reports earnings worse than estimates. In recent months, the 2 analysts from Thomson Reuters consensus have revised their EPS estimates upward.

Annual earnings per share is expected at 0.06 SEK for 2018 (- 72.7% from 2017). A summary of annual publications and estimates is available below.

Annual results20172018 (e)2019 (e)
Sales
Million SEK
Released
Forecast
Spread
141
120
18%

262

675
Operating income (EBITDA)
Million SEK
Released
Forecast
Spread
19,3
-12,0
261%

14,5

337
Operating profit (EBIT)
Million SEK
Released
Forecast
Spread
19,3
-13,5
243%

14,5

335
Pre-Tax Profit (EBT)
Million SEK
Released
Forecast
Spread
19,7
-35,0
156%

-58,0

329
Net income
Million SEK
Released
Forecast
Spread
15,2
-35,0
143%

-58,0

257
EPS
 SEK
Released
Forecast
Spread
0,22
-0,17
233%

0,06

2,96
Announcement Date02/20/2018

© MarketScreener.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOARCTIC AB
02/13BIOARCTIC : product candidate SC0806 for treatment of patients with complete spi..
AQ
02/11BIOARCTIC : U.S. Food and Drug Administration Approves Investigational New Drug ..
AQ
02/11BIOARCTIC AB : annual earnings release
02/07BIOARCTIC : Invitation to presentation of BioArctic's Full Year Report 2018 on F..
AQ
02/04BIOARCTIC : announces that Eisai will initiate Phase 3 confirmatory study with B..
AQ
2018BIOARCTIC : employs Gunilla Andersson as Senior Director HR
AQ
2018BIOARCTIC : AbbVie licences BioArctics Parkinsons disease portfolio
AQ
2018BIOARCTIC : outlicenses its alpha-synuclein antibody portfolio for Parkinson's D..
AQ
2018BIOARCTIC : to present at Jefferies 2018 London Healthcare Conference on Novembe..
AQ
2018BIOARCTIC : is awarded grant from EU's Horizon 2020 for participation in researc..
AQ
More news
Financials (SEK)
Sales 2019 502 M
EBIT 2019 83,6 M
Net income 2019 81,0 M
Finance 2019 1 138 M
Yield 2019 -
P/E ratio 2019 33,75
P/E ratio 2020
EV / Sales 2019 12,4x
EV / Sales 2020 26,4x
Capitalization 7 359 M
Chart BIOARCTIC AB
Duration : Period :
BioArctic AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOARCTIC AB
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 163  SEK
Spread / Average Target 63%
EPS Revisions
Managers
NameTitle
Gunilla Christina Osswald President & Chief Executive Officer
Wenche Nelly A. Rolfsen Sandsborg Chairman
Jan P. Mattsson Chief Financial Officer & Vice President-Finance
Christer Möller CSO & VP-Pre-Clinical Development
Hans Basun Chief Medical Officer & VP-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
BIOARCTIC AB21.83%792
IQVIA HOLDINGS INC11.13%28 377
CELLTRION, INC.--.--%23 803
LONZA GROUP14.80%21 653
INCYTE CORPORATION31.18%17 908
SEATTLE GENETICS, INC.17.42%11 477